KR20160139632A - Allium monanthum extracts of biological activity - Google Patents
Allium monanthum extracts of biological activity Download PDFInfo
- Publication number
- KR20160139632A KR20160139632A KR1020150074854A KR20150074854A KR20160139632A KR 20160139632 A KR20160139632 A KR 20160139632A KR 1020150074854 A KR1020150074854 A KR 1020150074854A KR 20150074854 A KR20150074854 A KR 20150074854A KR 20160139632 A KR20160139632 A KR 20160139632A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- water
- composition
- extraction
- solvent
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 109
- 241000981135 Allium monanthum Species 0.000 title abstract description 8
- 230000004071 biological effect Effects 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims abstract description 73
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 45
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 41
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 238000004519 manufacturing process Methods 0.000 claims abstract description 21
- 239000002537 cosmetic Substances 0.000 claims abstract description 17
- 230000000694 effects Effects 0.000 claims abstract description 15
- 239000004480 active ingredient Substances 0.000 claims abstract description 11
- 235000013305 food Nutrition 0.000 claims abstract description 11
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 3
- 238000009472 formulation Methods 0.000 claims description 24
- 238000000605 extraction Methods 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 22
- 244000068988 Glycine max Species 0.000 claims description 21
- 235000010469 Glycine max Nutrition 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 17
- 239000006071 cream Substances 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 11
- -1 pack Substances 0.000 claims description 10
- 206010009944 Colon cancer Diseases 0.000 claims description 8
- 208000029742 colonic neoplasm Diseases 0.000 claims description 7
- 235000016709 nutrition Nutrition 0.000 claims description 7
- 206010060862 Prostate cancer Diseases 0.000 claims description 6
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 5
- 239000000287 crude extract Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 235000013322 soy milk Nutrition 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 239000007901 soft capsule Substances 0.000 claims description 4
- 201000007270 liver cancer Diseases 0.000 claims description 3
- 208000014018 liver neoplasm Diseases 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000004071 soot Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims 3
- 239000000344 soap Substances 0.000 claims 3
- 239000004902 Softening Agent Substances 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- 230000003449 preventive effect Effects 0.000 claims 1
- 239000011877 solvent mixture Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 238000002137 ultrasound extraction Methods 0.000 claims 1
- 238000003809 water extraction Methods 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 abstract description 26
- 201000011510 cancer Diseases 0.000 abstract description 26
- 230000003078 antioxidant effect Effects 0.000 abstract description 22
- 230000001093 anti-cancer Effects 0.000 abstract description 19
- 239000003963 antioxidant agent Substances 0.000 abstract description 11
- 239000003814 drug Substances 0.000 abstract description 4
- 230000004663 cell proliferation Effects 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 239000002798 polar solvent Substances 0.000 abstract description 3
- 230000003064 anti-oxidating effect Effects 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 40
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 12
- 239000000523 sample Substances 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 235000006708 antioxidants Nutrition 0.000 description 10
- 239000002035 hexane extract Substances 0.000 description 10
- 241000195493 Cryptophyta Species 0.000 description 9
- 238000002376 fluorescence recovery after photobleaching Methods 0.000 description 9
- 229930014626 natural product Natural products 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 230000002292 Radical scavenging effect Effects 0.000 description 8
- 239000002024 ethyl acetate extract Substances 0.000 description 8
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 238000010609 cell counting kit-8 assay Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 235000013824 polyphenols Nutrition 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 239000002246 antineoplastic agent Substances 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 230000003833 cell viability Effects 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 235000013376 functional food Nutrition 0.000 description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 235000002634 Solanum Nutrition 0.000 description 4
- 241000207763 Solanum Species 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 3
- KMVWNDHKTPHDMT-UHFFFAOYSA-N 2,4,6-tripyridin-2-yl-1,3,5-triazine Chemical compound N1=CC=CC=C1C1=NC(C=2N=CC=CC=2)=NC(C=2N=CC=CC=2)=N1 KMVWNDHKTPHDMT-UHFFFAOYSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 108010087230 Sincalide Proteins 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 229940041181 antineoplastic drug Drugs 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 239000012454 non-polar solvent Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 2
- VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 2
- 241000234282 Allium Species 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000013736 caramel Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229930182486 flavonoid glycoside Natural products 0.000 description 2
- 150000007955 flavonoid glycosides Chemical class 0.000 description 2
- 229960002949 fluorouracil Drugs 0.000 description 2
- VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 description 2
- 235000008191 folinic acid Nutrition 0.000 description 2
- 239000011672 folinic acid Substances 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229960001691 leucovorin Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- ZZLHPCSGGOGHFW-ZMQIUWNVSA-N (2s)-2-amino-3-methylsulfinylpropanoic acid Chemical compound CS(=O)C[C@@H](N)C(O)=O ZZLHPCSGGOGHFW-ZMQIUWNVSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- XUHLIQGRKRUKPH-GCXOYZPQSA-N Alliin Natural products N[C@H](C[S@@](=O)CC=C)C(O)=O XUHLIQGRKRUKPH-GCXOYZPQSA-N 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000003445 Mouth Neoplasms Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- XUHLIQGRKRUKPH-UHFFFAOYSA-N S-allyl-L-cysteine sulfoxide Natural products OC(=O)C(N)CS(=O)CC=C XUHLIQGRKRUKPH-UHFFFAOYSA-N 0.000 description 1
- ZFAHNWWNDFHPOH-YFKPBYRVSA-N S-allylcysteine Chemical compound OC(=O)[C@@H](N)CSCC=C ZFAHNWWNDFHPOH-YFKPBYRVSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- XUHLIQGRKRUKPH-DYEAUMGKSA-N alliin Chemical compound OC(=O)[C@@H](N)C[S@@](=O)CC=C XUHLIQGRKRUKPH-DYEAUMGKSA-N 0.000 description 1
- 235000015295 alliin Nutrition 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000002792 antioxidant assay Methods 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000002034 butanolic fraction Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 201000005787 hematologic cancer Diseases 0.000 description 1
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- JQOAQUXIUNVRQW-UHFFFAOYSA-N hexane Chemical compound CCCCCC.CCCCCC JQOAQUXIUNVRQW-UHFFFAOYSA-N 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002700 inhibitory effect on cancer Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- VSIVTUIKYVGDCX-UHFFFAOYSA-M sodium;4-[2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)tetrazol-2-ium-5-yl]benzene-1,3-disulfonate Chemical compound [Na+].COC1=CC([N+]([O-])=O)=CC=C1[N+]1=NC(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)=NN1C1=CC=C([N+]([O-])=O)C=C1 VSIVTUIKYVGDCX-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
The present invention relates to a method for producing a soya extract having antioxidant and anticancer effects, and a cosmetic composition prepared by using the soya extract and the soya extract prepared by the above method.
Tumors are a collection of cells that exhibit autonomous overgrowth, distinguishing malignant tumors that may lead to death and benign tumors that are not. In particular, cancer is a genetic disorder caused by a mutation in genes such as oncogenes and tumor suppressor genes, and it is a cell-mediated disease. Cancer is widely classified into blood cancer and solid cancer, and it occurs in almost all parts of the body such as lung cancer, stomach cancer, breast cancer, oral cancer, liver cancer, uterine cancer, esophageal cancer and skin cancer.
Of the methods used to treat malignant tumors, chemotherapeutic agents other than surgery or radiation therapy are collectively referred to as anticancer drugs, and most of them exhibit anticancer activity by inhibiting the synthesis of nucleic acids. 5-fluorouracil (5-FU) is a water-soluble fluorinated pyrimidine analog, which has been widely used as an antitumor agent in the treatment of cancer, such as surgery, chemotherapy and radiation. (Kim et al., 2012). (Kanetaka et al., 2012), which is used alone or in combination with leucovorin (LV) for solid tumors such as liver cancer, stomach cancer, colon cancer, pancreatic cancer and breast cancer and has a plasma half- ), Bone marrow weakness, gastrointestinal reactions, leukopenia, and thrombocytopenia (Wettergren et al., 2012).
At present, many natural products are being used to improve health through immunity enhancement around the world. Drugs derived from natural products have been focused on active ingredients for the prevention and treatment of diseases. While traditional medicine books such as Dongbok-bong have mentioned the efficacy of natural products, the information in the literature is not associated with the current specific diseases or symptoms. In addition, it has not been revealed which of the ingredients of the natural product has a direct effect. Researches have been actively conducted to separate and extract substances exhibiting physiological activity contained in plants rather than directly using natural products known to have immunostimulating effects among natural products listed in Dongbokbo or Chinese Medicine Dictionary. At present, studies on tongoferol, phenolic substances, Maillard type browning products, amino acids, peptides, and the like are being conducted as physiologically active substances in natural products.
Allium monanthum Max. Is a perennial herbaceous plant belonging to the allium of Liliacase. It is a wild plant widely distributed in Northeast Asia including Korea, Japan, China and Mongolia. The general components contained in the algae were inorganic minerals such as calcium, phosphorus and iron in the outpost, 14 species in the anion, 15 species in the root, and 9 species in the leaves. In addition, fructose, glucose, sucrose and maltose have been reported in leaves and spermatozoa.
It is widely used not only for soothing food but also for medicinal purposes. The major medicinal effect is known to have an effect such as sterilization, hemostasis, blood, and nervous stability. The offensive odor of the garlic, onion (Allium sativum) I have a plant component, alliin, which is also called 3- (2-propenylsulfinyl) -L-alanine, S-allyl-L-cysteine sulfate. In addition, methyl alliin and scorodose have been reported as a component having antibacterial activity (Shanghai Science & Technology Press (1985) In "Encyclopedia of Chinese Drugs ", pp. 226, Shogakukan, Tokyo, Japan.).
The main researches on algae include taxonomic studies, cultivation studies, and bactericidal effects, and it has been reported that long - term treatment of algae affects serum lipid, sugar and protein content in rats. Among the components of soothing, many glycosylglyceride compounds have been studied in relation to anti-cancer and hyperlipidemia. However, there has been no report on the fractional extract of Alaskan which can maximize the anti-inflammatory activity and anticancer activity in the process of obtaining the extract from the algae so as to further enhance the industrial usefulness of algae.
In a study of Aoyama et al. (J. Korean Soc. Agric. Chem. Biotechnol., Vol. 43, No. 4, pp. 314-316 (2000) The polyphenols were firstly extracted with methanol, acidified with 5% hydrochloric acid / methanol solution, and then neutralized with neutralizing agent. Then, two kinds of flavonoid glycoside components were extracted from the extracts subjected to reduced pressure and concentration There have been reports on the extraction and analysis of the n - butanol fraction of the aloe vera which was confirmed to be able to extract the active ingredient through the extraction of silica gel column. However, there has been no report showing remarkable anti - cancer effect in addition to the antioxidative effect in the alum extract.
The deterioration of immune function is known to cause a variety of diseases including malignant tumors, breaking the homeostasis that maintains the balance of the living body due to deterioration of the processing function against the antigen from the outside. Especially, as the age increases, the severity of this phenomenon becomes more prominent and presents many problems in the coming aging society. It is well known that the ability of the immune response of a living body to become aged and deteriorate. It is also reported that the incidence of cancer in the liver and respiratory system is significantly increasing.
Cancer is a disease that has already progressed to disease and can not be cured by surgery. In such cases, cancer therapy or radiation therapy is tried, but its effect is not good and side effects are not satisfactory. Therefore, it is necessary to study the adjuvant which can be used together with anticancer drugs to reduce the side effects of anticancer drugs or to increase the anticancer effect, thereby improving the therapeutic effect and controlling the biological response.
Allium monanthum is a perennial plant belonging to Lillium. It has been widely used for its unique fragrance and taste. It has been widely used for sterilization, blood circulation, nervous stability, detoxification, And it has been proved that when the sole is administered to rats, the dietary efficiency, HDL-cholesterol and phospholipids of the rats are increased, and the serum total cholesterol and blood sugar are decreased, and thus it is effective in preventing adult diseases such as arteriosclerosis and diabetes mellitus have. However, there are few studies on the antioxidative and anticancer effects of the extracts of the soya extracts containing various herbal ingredients.
Accordingly, the present inventors intend to provide an extract having an antioxidant and anticancer effect, which comprises the extract of Solanum parvum as an active ingredient.
The compound of the present invention may be dried, preferably soaked in water to about 1 to 20 times, preferably about 3 to 15 times the dry weight of water, a C1 to C4 lower alcohol or a mixed solvent thereof, preferably Extraction with water, extraction with water, extraction with ultrasound, extraction with water or methanol at room temperature (20 to 100 ° C, preferably 20 to 30 ° C) extraction temperature for about 1 hour to 10 days, preferably about 20 hours to 30 hours, A first step of obtaining a crude extract by repeating extraction by 1 to 10 times, preferably 2 to 7 times, obtained by an extraction method such as reflux cooling extraction, preferably a reflux cooling extraction method, and then concentration under reduced pressure; The compound of the present invention can be obtained through a second-step preparation process in which the crude extract is suspended in water and then extracted with ethyl acetate and water, respectively.
More particularly, the present invention provides an extract having an anticancer activity activity of hepatocarcinoma, colon cancer, and prostate cancer against an extract containing the soya as an active ingredient.
1 is a graph showing cell viability (CCK-8 assay) of a water layer according to an embodiment of the present invention
2 is a graph showing cell viability (CCK-8 assay) of an ethyl acetate layer according to an embodiment of the present invention
3 is a graph showing the cell viability (CCK-8 assay) of the hexane layer according to the embodiment of the present invention
FIG. 4 is a graph showing the anti-cancer effect of the extract of the soya extract according to the embodiment of the present invention,
<Example 1> Preparation of the extract of Alumnae according to the present invention
2.4 kg of the dried soya used in the experiment was purchased from the budget and ground to a size of 30 meshes or less using a pulverizer. This was added to 15 l of 80% methanol solution and then subjected to primary extraction by reflux cooling at room temperature (24 ° C) for 24 hours. The residue was further extracted twice by the same method, and then added to the first extract to obtain the final extract. The above-obtained final extract was filtered and lyophilized to obtain a so-called crude extract (137 g). Extraction and separation of natural products in terms of production and industrialization related to known natural processes such as searching for unknown new substances in the early stages of natural products research and existing academic physiological activities. There is a separation method. Generally, the systematic extraction method used is extraction with petroleum ether, Et 2 O, CHCl 3 , MeOH, EtOH and H 2 O in that order. The organic compounds contained in the plant material are then extracted from the nonpolar material in order of increasing polarity. Solvent extraction can be carried out using a non-polar and polar solvent. Non-polar solvents are hexane (n-hexane), polar solvents such as methyl alcohol and ethyl alcohol, have. Methanol (methyl alcohol) is the most commonly used solvent for extracting physiologically active substances from plants. It is not only easy to extract various components, but also is easy to separate and purify after extraction. Therefore, when it is desired to test the physiological activity against a certain sample, it is usually extracted with methanol and then proceed to the next step. The methanol extract is immediately concentrated and lyophilized to give a methanol-extracted dry powder.
The crude extract (137 g) obtained in the above manner was suspended in water (2 L) and put into a separating funnel to carry out the fractional extraction of three layers. Separation of the liquids was carried out by adding 2 l of hexane and ethyl acetate twice, followed by shaking, and the soluble portion isolated by each of the extracts was obtained. Each soluble portion was concentrated with a vacuum concentrator. The hexane soluble extract obtained by the above method was about 30 g, the ethyl acetate soluble extract was about 30 g, and the water soluble extract was about 80 g.
The extract having an antioxidative effect in the above manner is contained in an amount of 0.1 to 30% by weight based on the total weight, and the remaining 70% of the extract includes tannin, a polysaccharide, and a phenone compound.
<Example 2> Antioxidant test for the extract of alumnaeus according to the present invention
DPPH, ABTS, FRAP assay and total polyphenol compound content assay were used for the antioxidant assay to determine the antioxidant levels of the extracts of the extracts from the extracts of hexane, ethyl acetate and water obtained in Example 1 above.
<2-1> DPPH Radical Scavenging activity analysis
Although direct measurement of the amount of active oxygen produced in the body or evaluation of the ability to absorb oxygen free radicals is the most ideal way to measure the reactive oxygen scavenging ability, Since much time is required, there is a limitation in measuring the activity of many samples. In this respect, the measurement of DPPH (1,1-diphenyl-picrylhydrazyl) radical scavenging activity is a fast, simple and economical method for measuring antioxidant activity. The DPPH radical scavenging activity method is widely used in food and other fields as a method of evaluating free radical scavenging ability and hydrogen donating ability of a sample. Most radicals are very unstable due to their reactivity, but the DPPH radical is a dark purple compound with a strong absorption at 517 nm as a stable free radical. However, when hydrogen is supplied from an antioxidant capable of scavenging free radicals, it changes to yellow when it becomes DPPHn, and the absorbance decreases at 517 nm. Therefore, the antioxidative activity of the sample can be simply measured using this principle. Antioxidant activity was measured by the Blois method (Blois, 1958), which measures the radical scavenging effect of DPPH.
1 mL of each extract was added to 1 mL of each concentration, and 0.2 mM DPPH solution (1 mL) was added. The mixture was shaken with a vortex mixer for 10 seconds, left in a dark room for 30 minutes, and then absorbed at 517 nm. BHA, a conventional antioxidant, was used as a control.
(E: experimental group, B: blank, C: control group)
As shown in Table 1, the free radical scavenging rate of the extracts of the algae was not higher than that of the conventional antioxidant BHA, but it was about 14% higher than that of ethanol extracts As a result, it was confirmed that the extract of ethyl acetate extract showed a relatively high antioxidant component among the extract components of soya extract.
<2-2> ABTS Radical Scavenging activity analysis
Total antioxidant activity was measured by ABTS radical scavenging method. That is, 7 mM ABTS and 140 mM potassium persulfate solution were mixed and allowed to stand in the dark for one day to form ABTS · +. This solution was then diluted with ethanol to an absorbance value of 0.7 +/- 0.02 at 734 nm. To 1 mL of the diluted ABTS · + solution, 50 μL of the diluted extract at a concentration of 20 mg / mL in methanol was added and the change in absorbance was measured after 3 minutes.
Table 2 shows the values of ABTS radical scavenging activity (ABTS IC 50 ) of 50%, and ABTS detection results were compared with vitamin C, which is a representative antioxidant.
In the ABTS radical scavenging ability, when extracting the active ingredient with the non-polar solvent hexane, the antioxidative properties of the extracts of polar water were about 2 times higher than those of the water extract of the polarity, which is about 100 times higher than that of the control sample vitamin C .
<2-3> FRAP Scavenging activity analysis
The reagents used in the FRAP assay were 10 mM TPTZ (2,4,6-tripyridyl-S-triazine) dissolved in 0.3 M acetate buffer (pH 3.6) and 40 mM hydrochloric acid (HCl) , And 20 mM ferric chloride (FeCl 3 ) solution were used. A pre-prepared sodium acetate buffer solution, a TPTZ solution and a ferric chloride solution (FeCl 3 ) were mixed at a ratio of 10: 1: 1 (volume ratio, v / v / v) To prepare FRAP samples. Using a methanol vortex mixer, mix 900 μl of the FRAP sample with 30 μl of the sample at a concentration of 20 mg / ml and 90 μl of distilled water. After incubation at 37 ° C for 10 minutes, the absorbance was measured at 593 nm. The results are shown in Table 3.
The antioxidant activity of the extracts of the soya using ethyl acetate was slightly different from the antioxidant activity of the extracts of hexane by the FRAP test method. This difference was significantly different from that of vitamin C, which is the highest control value .
The total polyphenolic compound content (TPC) was analyzed using the Folin-Ciocalteu method. 0.2 mL of Folin-Ciocalteu reagent (Sigma Chemical Co., St. Louis, Mo., USA) was added to 0.1 mL of each of the extracts and fractions diluted with methanol, and the mixture was maintained at 23 ° C for 1 minute. Then, 3 mL of 5% sodium carbonate (Na 2 CO 3 ) was added and the mixture was allowed to stand at 23 ° C for 1 hour. Absorbance was measured at 725 nm using a spectrophotometer (UV-1800, Shimadzu Co., Kyoto, Japan). The calibration curves were prepared using gallic acid (Sigma Chemical Co., St. Louis, Mo., USA) containing tannin components, and the content was calculated and shown in Table 4.
The water extract of dried soya has higher polyphenol content than the ethyl acetate or hexane extract. This indicates that the polyphenol component is better extracted from polar water, and the extract content of the polyphenol component is three times or more that of the weakly polar hexane extract.
The extracts of DPPH, ABTS, FRAP, and TPC, which were used as the antioxidant active ingredients of the soya extracts, showed the highest antioxidative activity in DPPH and FRAP assay The results are shown in Fig.
<Example 3> Analysis of anticancer activity according to the present invention
<3-1> Cancer cell line culture
In order to investigate the anticancer activity of the extract of the soya extract according to the present invention, the inhibitory effect on cancer cell proliferation of four cancer cells was analyzed.
The cancer cell lines used in the present invention were firstly transfected with HaCaT (Kera tinocyte) cells, human hepatocellular carcinoma cell line HePG2 (Hepatocarcinoma), human colon cancer cell line HCT 116 (Colon carcinoma) and human prostate cancer cell line CP3 (Prostatic carcinoma) Respectively.
HaCaT cells, HCT 116 cells, and PC3 cells were purchased from Korean Cell Line Bank (KCLB). HepG2 (Hepatocarcinoma) was purchased from the American Type Culture Collection (ATCC).
Each dispensed cell line was cultured in DMEM (Invitrogen, Carlsbad. CA) medium supplemented with 10% fetal bovine serum (FBS) and 100 units / mL penicillin and 10 ug / ml streptomycin And cultured in a 37 ° C incubator containing 5% CO 2 . After the cells were cultured for 2 weeks or more, the cell density was saturated to 70 ~ 80%. After the cells were incubated for 5 min with 0.05% trypsin-EDTA solution, the cells were subcultured.
<3-2> CCK -8 assay Using Cancer cell line Growth inhibition effect measurement
Analysis of dehydrogenase as a catalyst for redox reaction necessary for respiration reaction of organic compounds among methods for measuring cell viability for measuring the inhibitory effect of an extract on cancer cell growth by using microorganism activity measurement CCK-8 (Dojindo, Kumamoto, Japan), a kit for measuring cell numbers, was performed. CCK-8 was prepared by using tetrazolium salt (WST-8 *), which is near colorless, and samples were fractionated into HaCaT, HepG2, HCT116 and PC3 cells cultured on 96-well plates for 48 hours, 250 ㎍ / ml, cultured for 48 hours, CCK-8 was added to each well, and further incubated for 1 hour. Cell proliferation was expressed as a percentage of the absorbance of the control in the absorbance of the sample.
The results of inhibiting the cancer cell inhibitory effect as measured by the above method are shown in FIGS. 1 to 3, which are classified into water extract, ethyl acetate extract and hexane extract.
As a result of addition of each fraction extract, it was confirmed that as the concentration of the sample increases, the proliferation inhibition effect increases in all cancer cell lines.
When the water - soluble extract of the extracts from the water extracts was used at 250 ㎍ / ml, the inhibitory effect of HCT 116, a colon cancer cell line, was remarkable.
Compared with the cell inhibitory effect by the water soluble extract, the ethyl acetate soluble extract of FIG. 2 showed a 25% reduction in the cancer cell survival rate when treated with 100 ㎍ / ml or more in each cancer cell line, and 250 ㎍ / ml Treatment resulted in remarkable cancer cell survival lowering effect in all cancer cell lines. In particular, HCT116, a colon cancer cell line, showed a 50% decrease in cell viability, thus showing a remarkable anticancer effect of the extract of Solae extract of ethyl acetate.
Compared with the treatment effect of water and ethyl acetate soluble extracts of soleae, the extracts of Solanella hexane extract showed a remarkable effect on the decrease of survival rate of all cancer cells when treated with 100 ㎍ / ml or more. Especially, 116 showed a cell survival rate of less than 30% at 100 ㎍ / ml or more, indicating high anticancer effect. The results of treatment with the extracts of hexane extracts of 250 μg / ml or more showed a low cell survival rate of less than 50% in HepG2, HCT116 and PC3. Especially, treatment with HCT116, a prostate cancer cell line, and PC3, And 25%, respectively. Thus, the present invention is effective in inhibiting the growth of these cancer cells.
As a result of the above analysis, each of the extracts was treated with HaCaT, HepG2, HCT116, and PC3 cell lines cultured at 250 / / ml in order to exhibit anticancer effects of the fractions of the algae extracts. The cell culture DMEM medium (Dulbecco's Modified Eagle's Medium) As shown in Fig. From FIG. 4, it can be seen that, in the case of the extract obtained by extracting hexane from algae, HCT 116, which is a colon cancer cell line, and PC3 which is a prostate cancer cell line, cancer cell clearance is more remarkable than that of the control group, The difference in cancer cell clearance was found to be significantly different from that of the control group.
The anticancer effects of water, ethyl acetate, and hexane extracts obtained by extracting 80% methanol from the soya extracts were analyzed, and the anticancer effect of the extracts was confirmed. .
Example 4 Preparation of a Cosmetic Composition Using the Solanum Extract According to the Present Invention
The cosmetic composition of the present invention can be prepared by adding various known ingredients and the like to the skin by using a method known in the art to prepare a cosmetic composition containing nutritional lotion, softening longevity, nutritional cream, massage cream, essence, eye cream, cleansing water, cleansing cream, , A spray, and a powder.
Specifically, when the formulation of the cosmetic composition of the present invention is a paste, a cream or a gel or a pack, known components include animal fibers, plant fibers, waxes, paraffin, starch, tragacanth, cellulosic derivatives, polyethylene glycol, , Silica, talc or zinc oxide may be used.
When the formulation of the cosmetic composition of the present invention is a powder, lactose, talc, silica, aluminum hydroxide, calcium silicate, polyamide powder or the like may be used.
When the formulation of the cosmetic composition of the present invention is a solution or an emulsion, a solvent, a solvent or an emulsifier is used, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, , 3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or non-acidic esters of sorbitan, and the like.
When the formulation of the cosmetic composition of the present invention is a suspension, it may be diluted with water, a liquid diluent such as ethanol or propylene glycol, a suspension such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Stearylcellulose, aluminum metahydroxide, bentonite, agar or tragacanth, and the like can be used.
When the formulation of the cosmetic composition of the present invention is a detergent containing a surfactant, it is preferable to use a surfactant-containing detergent such as aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, Alkylamido betaine, aliphatic alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil or ethoxylated glycerol fatty acid ester, and the like can be used.
In addition, the cosmetic composition of the present invention can be prepared by any of the commonly known formulations such as stabilizers, solubilizers, vitamins, pigments, perfumes, and the like, And can be selected accordingly.
<4-1> Production of Nourishing Lotion Using Solanum Extract
As an example of the formulation, a composition of the nutritional lotion formulation among the cosmetics containing the extract of the soymilk of Example 1 was prepared by the composition of the following Table 5 and the following manufacturing method. 10, 11, 13, and 16 of Table 5 were heated to between 80 and 85 ° C with mixing and stirring, and then charged into the manufacturing section. Then, an emulsifier was operated and 2, 3, 4, 5, 6, 7, 8, To 85 ° C and then emulsified. After the emulsification was completed, the mixture was thermally cooled to 50 ° C. with stirring using an agitator, and then the mixture was cooled to 45 ° C. After the mixture was cooled to 45 ° C., the mixture was stirred at 35 ° C. and cooled to 25 ° C. A cosmetic product was obtained.
<4-2> Production of softened longevity using the extract
As an example of the formulation, the softening longevity was prepared by the composition of the following Table 6 containing the soothing extract of Example 1 and the following production method.
<4-3> Manufacture of Nourishing Cream by Using a Solanum Extract
As an example of the formulation, the nutritional cream was prepared by the composition of the following Table 7 containing the soothing extract of Example 1 and the following manufacturing method.
/ Glyceryl stearate
/ Polyoxyethylene stearate
<4-4> Manufacture of massage cream using algae extract
As an example of the formulation, the nutritional cream was prepared by the composition of the following Table 8 containing the soothing extract of Example 1 and the following manufacturing method.
<Example 5> Preparation of food using the extract of Alumnae according to the present invention
≪ 5-1 > Food Formulation Example 1: Soft capsule
As an example of the formulation, the health functional food of soft capsule was prepared by the following composition and the following production method containing the soothing extract of Example 1.
A soft capsule was prepared by mixing 400 mg of L-carnitine extract, 300 mg of L-carnitine, 180 mg of soybean oil, 2 mg of palm oil, 8 mg of vegetable hardening oil, 4 mg of yellow radish and 6 mg of lecithin per one capsule according to a conventional method.
≪ 5-2 > Food Formulation Example 2: Tablets
As an example of the formulation, the health functional food of tablets was prepared by the following composition and the following production method containing the extract of the soymilk of Example 1.
The extracts were mixed with 300 mg of extract, 300 mg of galactooligosaccharide, 150 mg of lactose, and 150 mg of maltose. The mixture was granulated using a fluidized bed drier, and 6 mg of sugar ester was added thereto.
≪ 5-3 > Food formulation example 3: Granule
As an example of the formulation, the health functional food of the granule was prepared by the following composition and the following production method containing the soothing extract of Example 1.
250 mg of anhydrous crystalline glucose and 450 mg of starch were mixed and granulated into granules using a fluidized bed granulator and filled in a capsule.
≪ 5-4 > Food formulation example 4:
As an example of the formulation, the health functional food of the drink was prepared by the following composition and the following production method containing the soot extract of Example 1.
300 mg of the extract, 300 mg of glucose, 10 g of citric acid, 0.6 g of citric acid, and 25 g of liquid oligosaccharide are mixed, and 300 ml of purified water is added. And then sterilized at 130 DEG C for 4 to 5 seconds to prepare a beverage.
≪ 5-5 > Food formulation example 5: Caramel formulation
As an example of the formulation, the health functional food made of caramel was prepared by the following composition and the following production method containing the extract of the soymilk of Example 1.
10 g of the soya extract, 1.8 g of corn syrup, 1.0 g of skim milk, 1.0 g of soybean lecithin, 0.6 g of butter, 0.4 g of vegetable cured oil, 1.4 g of sugar, 0.58 g of margarine and 20 mg of salt were mixed and caramelized .
It will be understood by those skilled in the art that the foregoing description of the present invention is for illustrative purposes only and that those of ordinary skill in the art can readily understand that various changes and modifications may be made without departing from the spirit or essential characteristics of the present invention. will be. It is therefore to be understood that the above-described embodiments are illustrative in all aspects and not restrictive.
Claims (12)
Crushing the dried soot;
Mixing pulverized soap and solvent; The mixed solution was adjusted in temperature and time
extraction;
The extracted solution was concentrated under reduced pressure; A soya extract prepared by freeze-drying
;
Suspending the sooty crude extract in water;
And a step of fractionating the above-mentioned suspended solu- tion extract with a solvent
≪ / RTI >
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150074854A KR20160139632A (en) | 2015-05-28 | 2015-05-28 | Allium monanthum extracts of biological activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150074854A KR20160139632A (en) | 2015-05-28 | 2015-05-28 | Allium monanthum extracts of biological activity |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20160139632A true KR20160139632A (en) | 2016-12-07 |
Family
ID=57572649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150074854A KR20160139632A (en) | 2015-05-28 | 2015-05-28 | Allium monanthum extracts of biological activity |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20160139632A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200086914A (en) * | 2019-01-10 | 2020-07-20 | 주식회사농심 | Composition for enhancing immunity, pharmaceutical and functional food having the composition |
KR20220003878A (en) * | 2020-07-02 | 2022-01-11 | 충남대학교산학협력단 | Composition for preventing, improving or treating prostate disease comprising extract of Allium macrostemom Bunge as effective component |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100084209A (en) | 2009-01-16 | 2010-07-26 | 서원대학교산학협력단 | Cosemtics composition containing the extract of allithiamine fermented |
KR101211937B1 (en) | 2012-09-18 | 2012-12-13 | 주식회사 들레네 | Functional fermented wild plants having anti-inflammatory effect using 101 wild plants extracts |
-
2015
- 2015-05-28 KR KR1020150074854A patent/KR20160139632A/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100084209A (en) | 2009-01-16 | 2010-07-26 | 서원대학교산학협력단 | Cosemtics composition containing the extract of allithiamine fermented |
KR101211937B1 (en) | 2012-09-18 | 2012-12-13 | 주식회사 들레네 | Functional fermented wild plants having anti-inflammatory effect using 101 wild plants extracts |
Non-Patent Citations (1)
Title |
---|
"식용 식물자원으로부터 활성물질의 탐색-III. 달래(Allium monanthum Max.)로부터 flavonoid 배당체의 분리", J. Korean Soc. Agric. Chem. Biotechnol. Vol. 43, No. 4, pp. 314~316 (2000). |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200086914A (en) * | 2019-01-10 | 2020-07-20 | 주식회사농심 | Composition for enhancing immunity, pharmaceutical and functional food having the composition |
KR20220003878A (en) * | 2020-07-02 | 2022-01-11 | 충남대학교산학협력단 | Composition for preventing, improving or treating prostate disease comprising extract of Allium macrostemom Bunge as effective component |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4644787B2 (en) | Anti-obesity agent having lipase inhibitory activity and antioxidant properties | |
EP3017822B1 (en) | Composition for treating or preventing inflammatory skin disease, comprising, as active ingredient, immature citrus fruit extract, or synephrine or salt thereof | |
JP2008531584A (en) | Composition comprising the genus Matabia and method of using the same | |
KR101367423B1 (en) | Pharmaceutical composition and cosmetic compostion for improving skin condition and preparation method thereof | |
KR20150050310A (en) | Composition for improving skin conditions comprising artemisiae annuae herba, neem leaf, centella asiatica and green tea extract or fraction thereof and method for improving skin conditions using the same | |
JP2010143862A (en) | Composition containing plant extract | |
WO2005051406A1 (en) | Ceramidase inhibitor | |
JP4836961B2 (en) | Expression inhibitor of nuclear transcription factor AP-1, pharmaceutical and product using the same | |
KR101996732B1 (en) | Cosmetic composition comprising concentrate of Omegiju fermented using magma seawater for improving wrinkles, elasticity or moisturizing the skin | |
JP5309292B2 (en) | Lipase inhibitor | |
KR102355143B1 (en) | Method for preparing fermentated ziziphus jujuba seed | |
KR102153355B1 (en) | A composition comprising Caulerpa racemosa extracts or fraction having anti-oxidation or anti-inflammation activity | |
JP6636467B2 (en) | Composition containing extract of autumnal soybean leaves and method for producing the same | |
KR20160139632A (en) | Allium monanthum extracts of biological activity | |
JP2008013481A (en) | Tyrosinase activity inhibitor and lipoxygenase activity inhibitor derived from alpinia speciosa | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR20180110411A (en) | Cosmetic composition for skin improvement Containing Orostachys japonicus extract | |
KR101069906B1 (en) | A composition for improving skin conditions comprising extract of Aster subulatus Michx. | |
JP5294847B2 (en) | Moisturizer, whitening agent and slimming agent | |
KR102292114B1 (en) | Composition for Improving Skin Conditions Having Moisturizing, Anti-Inflammatory Caused by Fine Dust and Pore Shrinkage Property Comprising Plant Complex Extracts as Active Ingredient | |
JP2004155961A (en) | Antioxidant | |
KR20160036823A (en) | Health functional food for preventing or treatment tumor | |
KR102443334B1 (en) | Composition with Anti-Inflammation, Skin Moisturizing, Pruritis Improving, and Skin Regeneration Property Comprising Complex Extract of Hibiscus Syriacus as Active Ingredient | |
KR102355138B1 (en) | Composition for whitening or anti-wrinkle of the skin comprising fermentated ziziphus jujuba seed as effective component | |
KR101625598B1 (en) | Manufacturing method for extract of natural products using traditional process and anti-aging cosmetic composition containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |